Hong Kong lags on Esma equivalence

Esma unable to grant equivalence on Hong Kong's OTC clearing regime as framework is not yet in place


Hong Kong is lagging behind other Asian jurisdictions in gaining European Securities and Markets Authority (Esma) recognition on the equivalence of its over-the-counter derivative regulatory regime as laws to implement its OTC derivatives framework are still in the process of being passed.

In its second round of equivalence determinations on October 2, Esma has granted India and South Korea third-country regulatory conditional equivalence for central counterparties (CCPs) while Singaporean trade

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

Switching CCP – How and why?

As uncertainty surrounding Brexit continues and the impacts of Covid-19-driven market volatility are analysed, it is essential for banks and their end-users to understand their clearing options, and how they can achieve greater capital and cross…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here